FORUM OVERVIEW

SIIA members consistently cite Cell & Gene Therapy (CGT) as one of the hottest topics affecting the self-insurance industry today, with the likelihood that it will be even more impactful in the years ahead.  Join leading experts in the field as well as thought leaders within the self-insurance industry who will cover this topic from multiple angles.

You will leave with detailed knowledge of the CGT pipeline, manufacturer and provider perspectives on pricing, value-based pricing considerations, potential financial mitigation/risk strategies, plan document guidance and more.  Attendees will also have multiple opportunities to engage directly with each other, which promises to maximize the knowledge-sharing experience and to help facilitate business partnership opportunities.  

Thank you to our Sponsor!